Mette
Mette Christensen, Valby DK
Patent application number | Description | Published |
---|---|---|
20100010072 | MICRORNA BIOMARKERS FOR HUMAN BREAST AND LUNG CANCER - The present invention relates to novel molecular markers for diagnosis and classification of human breast cancer and lung cancer. | 01-14-2010 |
20130296399 | microRNA Biomarkers for Human Breast and Lung Cancer - The present invention relates to novel molecular markers for diagnosis and classification of human breast cancer and lung cancer. | 11-07-2013 |
Mette Dyhrberg, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20140282148 | Monitoring and Collaborative Analysis of a Condition - The disclosed technology relates to computer hardware and software systems for variably monitoring a condition relating to a first user, receiving data relating to the condition, and for facilitating the collaborative analysis of the captured data by presenting a second user with an interface for reviewing the data. The text, drawings and claims of the disclosure detail various additional embodiments of the disclosed methods, systems, and computer products. | 09-18-2014 |
Mette Ejrnaes, Franklin Lakes, NJ US
Patent application number | Description | Published |
---|---|---|
20150093764 | BLOCKING REAGENT COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME - Blocking reagent compositions, as well as methods of making and using the same, are provided. Aspects of the composition include a blocking reagent that binds to the cell surface but does not specifically bind to a targeted first cell surface antigen. Also provided are system and kits that include the compositions. | 04-02-2015 |
Mette Faergemand, Alleroed DK
Patent application number | Description | Published |
---|---|---|
20120021093 | METHOD FOR PRODUCING AN ACIDIFIED MILK PRODUCT - The present invention relates to a method for producing an acidified milk product using an enzyme having transglutammase activity. | 01-26-2012 |
Mette Fanefjord, Lyngby DK
Patent application number | Description | Published |
---|---|---|
20130131334 | METHOD FOR THE SYNTHESIS OF A TRISACCHARIDE - The present invention relates to an improved synthesis of a trisaccharide of the formula (1), novel intermediates used in the synthesis and the preparation of the intermediates. | 05-23-2013 |
Mette Gronborg, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20080318853 | Diagnostic and Therapeutic Use of a Novel Growth Factor, Neublasmin - The present invention relates to the field of diagnostic and therapeutic use of proteins and genes, in particular to the diagnostic and therapeutic use of a secreted human hormone/growth factor, Neublasmin, and use or the gene coding for Neublasmin in the diagnosis and treatment of testicular disorders, in particular diagnosis and treatment of germ cell tumours and infertility. The invention also relates to use of Neublasmin in the treatment of CNS disorders. Neublasmin is expressed at high levels in human adult testicles and in developing mouse testicles from pn 22 and onwards. Expression or Neublasmin is strongly up-regulated in carcinoma in situ. Expression is also seen in foetal and adult brain. | 12-25-2008 |
20090087474 | Therapeutic use of growth factors,nsg29 and nsg31 - The present invention relates to the field of therapeutic use of proteins, genes and cells, in particular to the therapy based on secreted therapeutic proteins, NsG29 and NsG31. NsG29 and Ns31 are members of a newly identified family of growth factors with a specific cystein pattern and characterised by expression in the nervous system. The secreted growth factors have potential for the treatment of disorders of the nervous system. The invention also relates to bioactive NsG29 and NsG31 polypeptide fragments and the corresponding encoding DNA sequences. | 04-02-2009 |
20090136552 | Growth factors nsg28, nsg30, and nsg32 - Disclosed are NsG28, NsG30, NsG32 polypeptides, nucleic acids encoding NsG28, NsG30, NsG32 polypeptides, and antibodies that bind to NsG28, NsG30, NsG32 polypeptides as well as methods of making and using the same. | 05-28-2009 |
Mette Grønborg, Copenhagen DK
Patent application number | Description | Published |
---|---|---|
20120184492 | THERAPEUTIC USE OF A GROWTH FACTOR, NSG33 - The present invention relates to the field of therapeutic use of proteins, genes and cells. More specifically the invention relates to therapy based on the biological function of a secreted therapeutic protein, NsG33, in particular for the treatment of disorders of the nervous system. NsG33 is a nerve survival and growth factor with antiapoptotic effects on a cell line with neuronal potential and with neuroprotective and/or neurogenesis effects on a neural precursor cell line and on primary striatal cultures. The invention also relates to novel bioactive NsG33 polypeptide fragments and the corresponding encoding DNA sequences. | 07-19-2012 |
Mette Guldbrandt, Farum DK
Patent application number | Description | Published |
---|---|---|
20130143815 | GROWTH HORMONE CONJUGATES - The present invention relates to growth hormone conjugates comprising a bile acid residue, said conjugation may occur through wt or mutant amino acid residues. The growth hormone polypeptide may be wt human growth hormone or a growth hormone variant. | 06-06-2013 |
Mette Husbyn, Oslo NO
Patent application number | Description | Published |
---|---|---|
20090191123 | NOVEL IMAGING AGENTS - The present invention provides a novel imaging agent suitable for the non-invasive visualization of fibrosis. A precursor for the preparation of the imaging agent is also provided by the invention, as well as a pharmaceutical composition comprising the imaging agent and a kit for the preparation of the pharmaceutical composition. In a further aspect, use of the imaging agent for in vivo imaging and in the preparation of a medicament for the diagnosis of a condition which comprises fibrosis is provided. | 07-30-2009 |
20100105888 | SEPARATION PROCESS - The present invention relates to a process for separating a target radiolabelled compound from an impurity, apparatus for performing such a process and a removable cassette for use in such apparatus. Also provided are methods for using the target radiolabelled compound obtained by a method comprising the separating process of the invention. | 04-29-2010 |
20120138520 | SEPARATION PROCESS - The present invention relates to a process for separating a target radiolabelled compound from an impurity, apparatus for performing such a process and a removable cassette for use in such apparatus. Also provided are methods for using the target radiolabelled compound obtained by a method comprising the separating process of the invention. | 06-07-2012 |
Mette Lægdsmand, Viborg DK
Patent application number | Description | Published |
---|---|---|
20150147770 | EMBRYO QUALITY ASSESSMENT BASED ON BLASTOCYST DEVELOPMENT - The present invention relates to a method and to a system for selecting embryos for in vitro fertilization based on observed cell kinetics and cell morphology. One embodiment of the invention relates to a method for determining embryo quality comprising monitoring the embryo for a time period, said time period comprising the transformation of the embryo from initial compaction or morula to blastocyst and determining one or more blastocyst quality criteria for said embryo, and based on said one or more blastocyst quality criteria determining the embryo quality. | 05-28-2015 |
Mette Langaas, Trondheim NO
Patent application number | Description | Published |
---|---|---|
20140057800 | SINGLE NUCLEOTIDE POLYMORPHISM ASSOCIATED WITH RISK OF INSULIN RESISTANCE DEVELOPMENT - The present invention is directed to methods of identifying quantitative trait loci (QTL) markers associated with insulin resistance, and use of these markers to explain individual physiological responses to dietary glycemic load. In addition, expressional QTLs (eQTLs) have been identified to characterize the contribution of the genotype to variations in gene expression. | 02-27-2014 |
Mette Østberg, Egaa DK
Patent application number | Description | Published |
---|---|---|
20120210587 | DRAWING DEVICE FOR CREATING MANDALA - A drawing device for creating Mandala includes a single molded unit of a base plate, a support surface, and an outer frame, with the support surface being slightly recessed in relation to the bordering outer frame and the inner frame having the exact measurements of the support surface. The inner frame contains one or several voids within it and is positioned inside the outer frame on the drawing material lying on the support surface, and stencils(s) shaped to fit precisely into the matching void(s) of the inner frame can be positioned onto the drawing material lying on the support surface, allowing for the stencil to be rotated or mirrored repeatedly within the void of the inner frame while still maintaining its exact center point due to the void(s) and stencil(s) being non-circular, exhibiting at least at three edges. | 08-23-2012 |
Mette Owner-Petersen, Molndal SE
Patent application number | Description | Published |
---|---|---|
20140233087 | REFERENCE CALIBRATION FOR AN ADAPTIVE OPTICS SYSTEM - A method of determining a reference calibration setting for an adaptive optics system ( | 08-21-2014 |
Mette Schrøder, Valby DK
Patent application number | Description | Published |
---|---|---|
20110265557 | Method of Quality Control Testing a Factor XIII Containing Sample - The invention relates to a method of quality control testing a Factor XIII (FXIII) containing sample which comprises the step of detecting the presence of and/or measuring the concentration of pre-activated FXIII (FXIIIao) in said sample and to a quality control kit for determining the quality of a Factor XIII (FXIII) containing sample. Preferably, an anion-exchange chromatographic column is used, as well as the fluorescent substrate Abz-NE (Cad-Dnp) EQVS PLTLLK-OH. | 11-03-2011 |
Mette Solvang, Roskilde DK
Patent application number | Description | Published |
---|---|---|
20120183758 | MINERAL FIBRES AND THEIR USE - The invention relates to mineral fibres formed of a composition comprising the following oxides, by weight of composition: —SiO | 07-19-2012 |